Spain · AEMPS CIMA

AMOXICILINA/ACIDO CLAVULANICO CINFA 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
66567
Form
POLVO PARA SUSPENSIÓN ORAL
Composition / generic term
amoxicilina + ácido clavulánico
Source strength
Amox. (trihidr)a.clav. 875-125 mg/sobre monod.
Authorisation holder
Laboratorios Cinfa S.A.
Marketed in source snapshot
Yes

Source-listed ingredients

  • CLAVULANICO ACIDO — 125 mg
  • AMOXICILINA — 875 mg

These values do not establish equivalence or a dose recommendation.

Packages

  • AMOXICILINA/ACIDO CLAVULANICO CINFA 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG, 20 sobres
  • AMOXICILINA/ACIDO CLAVULANICO CINFA 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG, 30 sobres
  • AMOXICILINA/ACIDO CLAVULANICO CINFA 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG, 500 sobres

Source and coverage

Open AEMPS CIMA →

Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Spain records →